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Objective. To identify adherence to Mediterranean diet among two groups of Spanish adults: diabetic patients and nondiabetic
subjects. Methods. Adherence to Mediterranean diet was measured by a 14-item screener (scale: 0–14; ≤5: low, 6–9: moderate,
and ≥10: high) in 351 volunteers. Results. Mean age was 50.97± 12.58 in nondiabetics (n = 154) and 59.50± 13.34 in
diabetics (n = 197). The whole sample scored 8.77± 1.82. Score was 9.19± 1.84 in nondiabetic females (n = 58) and 8.15± 1.79 in
diabetic females (n = 85) (p = 0 003), due to lower consumption of olive oil (p = 0 005) and nuts (p = 0 000). Type 2 diabetic males
(n = 79; 8.76± 1.88) consumed less olive oil than healthy males (n = 28; 9.36± 1.59) (p = 0 046). Up to 30-year-old nondiabetics
scored lower than more than 60-year-old nondiabetics (8.40± 1.5 versus 9.74± 2.03; p = 0 047). The youngest ate less olive oil
(p = 0 002) and more pastries (p = 0 007). Conclusions. The sample presented moderate adherence to Mediterranean diet in all
subgroups. Scientific evidence about the benefits of Mediterranean diet, olive oil, and nuts supports the recommendation to
increase consumption of olive oil and nuts in diabetic women and of daily olive oil in type 2 diabetic men, reducing
consumption of red meat, butter, and pastries, and to promote Mediterranean diet among the youngest of the sample studied.
1. Introduction
Lifestyle interventions, including diet control, have shown
improvement in cardiovascular risk factors in patients with
diabetes [1, 2]. Nutritional education in these patients has
traditionally been based on low-fat diets and low-
carbohydrate diets. Mediterranean diet, characterized by
higher consumption of plant-based foods, comprises the
following: high intake of fruits, vegetables, wholegrain
products, legumes, fish, plant proteins, and unsaturated
fatty acids (olive oil and nuts); moderate consumption of
alcohol (mostly wine, preferably consumed with meals);
and low consumption of (red) meat, commercial sweets or
pastries, and low saturated fatty acids—fat [3].
Energy contributed by fat oscillates is between 25 and
35% of the total energy (calories), while energy provided by
saturated fat is at most 7–8%. Important sources of fats are
olive oil, nuts, seeds, and blue fish. Fat composition of Med-
iterranean diet has the following characteristics: high in
monounsaturated fats, particularly oleic acid mainly from
olive oil. Balanced in polyunsaturated fats (omega 6 and
omega 3). Nuts and seeds are an important source of these
fats. High consumption of long-chain omega-3 polyunsatu-
rated fats (eicosapentaenoic acid and docosahexaenoic acid)
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from fish and olive oil (due to its content of linoleic and lino-
lenic acids, precursors of arachidonic, eicosapentaenoic, and
docosahexaenoic acids). Low in saturated fats, thanks to low
consumption of butter and red meats. Absence of trans fats
from industrial foods (margarines, fast food, and pastries).
Proteins account for about 15% of total calories. Proteins
in Mediterranean diet come from various sources: legumes,
nuts, white meats, fish and seafood, cheese, and yogurt. It is
characterized by being relatively low in animal proteins.
Carbohydrates provide about 50% of total daily energy
intake. Mediterranean diet is distinguished by being rich in
complex carbohydrates, derived from cereals (bread, pasta),
legumes, and various vegetable foods.
Glycemic index is considered quite low, due to large pro-
portion of foods with low glycemic index, such as legumes,
fruits, and vegetables, despite the consumption of other foods
such as bread and honey (typical of Mediterranean diet) that
have higher glycemic indexes.
Mediterranean diet is particularly rich in fiber and
vegetable antioxidants, due to high consumption of various
vegetable foods.
Relevant bibliography in recent years has demonstrated
more favourable changes in fasting plasma glucose and
insulin levels with moderately hypocaloric Mediterranean
diet than with low-fat diet, and it has shown the same efficacy
in weight loss in obese patients as low-carbohydrate or
low-fat diets [4]. Furthermore, it has been proven that
even a modest weight loss is related with an improvement
in insulin sensitivity following a moderately hypocaloric
Mediterranean diet [5].
In addition, Mediterranean diet reduces incidence of
diabetes by 52% compared to a low-fat diet, in the absence
of changes in body weight or physical activity [6, 7]. An
Australian cohort study has shown reductions in total
and diabetes mellitus-associated mortality in population
(including European migrants) with greater adherence to a
Mediterranean diet pattern [8].
Mediterranean diet enhanced with virgin olive oil and
nuts was effective in inducing regression of carotid athero-
sclerosis among subjects with elevated baseline carotid
intima-media thickness [9]. It has been shown that Mediter-
ranean diet protects from the obesity risk allele action on the
development of type 2 diabetes regardless of BMI [10].
Prevención con Dieta Mediterránea (PREDIMED) trial
showed that Mediterranean diet supplemented with extra-
virgin olive oil and nuts was useful to prevent cardiovascular
disease in comparison with a low-fat diet [11]. Adherence to
Mediterranean diet has been associated with lower incidence
of cardiovascular disease regardless of the level of cardiovas-
cular risk in a population with major cardiovascular risk fac-
tors [12]. Mediterranean dietary intervention may mitigate
potential deleterious effects of elevated plasma ceramide
concentrations (intermediate link between overnutrition
and pathological mechanisms underlying cardiovascular
disease) [13]. It is known that omega-3 polyunsaturated fatty
acids, which are abundant in nuts, reduce triglyceride
synthesis [14] and that olive oil has been associated with a
greater amount of prostaglandin trienoic, which results in an
increase in serumHDL-c [15].
Insulin resistance is the major determinant of type 2
diabetes mellitus. It is a multifactorial condition in which
low-grade and chronic tissue inflammation is a major and
documented contributor [16]. Type 1 diabetes is associated
with increased risk of micro and macrovascular complica-
tions, and coronary artery disease is the main cause of death
in type 1 diabetes. Type 1 diabetic population exhibits
increased inflammation as evidenced by increased plasma
C-reactive protein levels and increased monocyte proathero-
genic activity [17].
Mediterranean diet has shown to play a role in reducing
inflammatory state. Food antioxidants (fruits, vegetables,
and nuts), reduction of saturated and trans fats, adequate
omega-3 fatty acids, and dietary fiber intake have been
suggested as Mediterranean diet components which may
have anti-inflammatory roles [18].
Consumption of monounsaturated fatty acids in vivo has
been related to improve insulin sensitivity [19]. Fish oils
including omega-3 polyunsaturated fatty acids exert anti-
inflammatory effects [20] through the inhibition of inflamma-
some (a component of the innate immune system) activation
[21]. Inflammasome is a cytosolic protein complex assembled
in response to pathogen infection or injury and promotes
maturation and release of several proinflammatory cytokines.
Inflammatory response includes a process that produces
a superfamily of chemical mediators that stimulate resolution
of inflammatory responses. Specialized proresolving media-
tors are physiologic endogenous mediators and pharmaco-
logic agonists that stimulate resolution of inflammation and
infection. They include omega-3-derived families: resolvins,
protectins, and maresins, as well as arachidonic acid-
derived (n-6) lipoxins [22].
These biochemical pathways might explain at least in
part the favourable effect of Mediterranean diet on glucose
and insulin levels.
Metabolic syndrome, which can precede or partner with
the development of type 2 diabetes mellitus, is also accompa-
nied by a proinflammatory state associated with both insulin
resistance and endothelial dysfunction. The link between
inflammation and endothelial dysfunction, and subsequent
cardiovascular disease, is oxidative stress. Inflammatory pro-
cesses promote the production of reactive oxygen species
which in turn stimulates mediators of proinflammatory
state-like nuclear factor kappa B, cytokines, activator pro-
tein-1, vascular cell adhesion molecule 1, and intercellular
adhesion molecule 1 [23].
Biochemical studies in the prevention mechanism of
Mediterranean diet in atherosclerotic vascular disease have
shown the main protection proceed from virgin olive oil
and red wine. Hydroxytyrosol, oleuropein (olive oil poly-
phenols), resveratrol, and quercetin (red wine polyphenols)
have shown to reduce inflammatory angiogenesis in vitro
through reduced intracellular oxidative stress [24]. The
complete polyphenol fraction from olive oil has been able
to lower oxidative stress and inflammatory angiogenic
responses associated with chronic degenerative diseases in
endothelial cells [25].
Another complication highly prevalent in patients with
diabetes mellitus is nonalcoholic fatty liver disease. Higher
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adherence to Mediterranean diet has been associated with
less degree of insulin resistance and less severe liver disease
among patients with nonalcoholic fatty liver disease [26],
may be mediated by oleuropein, an olive oil’s phenolic com-
pound. Oleuropein-supplemented high fat diet-fed mice
have shown less hepatic proinflammatory cytokines and less
hepatic concentration of cholesterol, triglycerides, and free-
fatty acids which have led to a more positive evolution of
hepatic steatosis [27]. Thus, Mediterranean dietary pattern
has been recommended for nonalcoholic fatty liver disease
management [28].
These evidences attest to the interesting possibility that
Mediterranean diet may play a significant role in the preven-
tion of complications of both type 1 and type 2 diabetes
mellitus. Therefore, to promote adherence to Mediterranean
diet of diabetic population may be a key factor in the
management of the disease.
1.1. Aims. The main purpose of this study was to identify
adherence to Mediterranean diet among two groups of
Spanish adults: diabetic patients and nondiabetic subjects.
Specifically, we aimed to analyse the differences between
the two groups, due to educational efforts made to modify
diabetic population eating habits and to identify the food
groups to influence with nutritional education.
2. Materials and Methods
2.1. Design. A cross-sectional study was done with two
participating groups selected from one Spanish medical
centre population: one group of nondiabetic subjects and
one group of diabetic patients.
2.2. Study Participants. Study participants (351) were a
sample of volunteers recruited via nursing staff from the
population of the Spanish medical centre “Grande Covian
Specialty Medical Centre.”
Members of the population were asked if they would take
part in the research when they attended usual medical centre
activity and consultations and the information events held in
the centre to mark the celebration of the May 28 World
Nutrition Day.
Subjects who met the following criteria were eligible for
the study: at least 18 years of age and given informed consent
and male or female between the age of 18 and 90.
Subjects who met any of the following criteria were not
eligible for the study: inability to fully comprehend and/or
perform study procedures and subjects with very patent
alteration of their cognitive functioning.
After advertising, 197 subjects volunteered for the
diabetic group and 154 for the nondiabetic group.
The study was conducted in accordance with the Decla-
ration of Helsinki (1964). The institution approved the study
protocol, and all participants provided informed consent.
The sample size calculation indicated that the 351 sub-
jects included in the study were sufficient to detect a differ-
ence of 0.6 points in the total score of the Mediterranean
diet adherence screener between diabetic and nondiabetic
subjects in a two-sided test, assuming a common standard
deviation (SD) of 1.8 points with a significance level of 95%
and a power of 80%.
2.3. Measurements
2.3.1. 14-Item Mediterranean Diet Adherence Screener
Score. Adherence to Mediterranean diet was measured by a
14-item Mediterranean diet adherence screener (Table 1),
previously validated in adult Spanish population [29].
If the condition is not met, 0 points are recorded for the
item. The final score ranges from 0 to 14; the greater the
score, the greater the adherence to Mediterranean diet.
Martínez-González et al. classified participants according to
three Mediterranean diet adherence categories (≤5 points:
low adherence, 6–9 points: moderate adherence, and ≥10
points: high adherence) [30].
2.4. Statistical Analysis. Analyses were performed with SPSS
software package version 22.0 (SPSS Inc., Chicago, Illinois).
Means (SD) or percentages were calculated for the 14-item
dietary screener score across categories, and statistical signif-
icance of the differences was assessed with Mann–Whitney U
test and chi-square test (if any of the cells had an expected
count below 5, then Fisher exact test was applied). Compar-
isons were done between diabetic and nondiabetic subjects
(separately for women and men), between type 1 diabetes
and type 2 diabetes (separately for women and men), and
between age groups (3 categories: 0–30/31–60 and 61–90
years) separately for diabetic and nondiabetic subjects.
Spearman rank correlations were calculated between the
duration of diabetes and the 14-item score, for the whole
diabetic group and separately for type 1 diabetic subjects
and type 2 diabetic subjects.
Nonparametric tests were chosen because the dependent
variable showed a nonnormal distribution. Statistical signifi-
cance was set at two-sided p < 0 05. We did not use any
imputation method for missing data.
3. Results
Mean (±SD) age of the whole sample was 56.25± 13.6 years,
in type 1 diabetic subjects was 46.78± 12.13, in nondiabetic
subjects was 50.97± 12.58, and in type 2 diabetic subjects
was 64.42± 10.87. Age differences among study subgroups
are shown in Table 2.
For the whole sample, 14-item dietary screener score
mean (±SD) was 8.77± 1.82 points on the 0 to 14 score.
The 14-item score in nondiabetic subjects was 9.06± 1.78
and in diabetics was 8.54± 1.81.
We did not observe significant correlations in the 14-item
score depending on the duration of diabetes (Table 3).
Nondiabetic participants scored higher on the total 14-
item score than diabetics (p = 0 006). There were also differ-
ences between men and women with diabetes (p = 0 023)
(Table 4). There were no differences between nondiabetic
men and women. Percentages in adherence categories to
Mediterranean diet for each participant subgroup can be
observed in Table 4.
There were no differences between type 1 and 2
diabetics (Table 5).
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Diabetic women (8.15± 1.79) showed differences with
nondiabetic women (9.19± 1.84) (p = 0 003), both type 1
(7.92± 1.6) (p = 0 012) and type 2 (8.12± 1.94) (p = 0 005).
Among men subgroups, there were no differences
(p = 0 08).
Figure 1 reflects the percentage of women with positive
criteria for 1 point in each of the 14 items of the dietary
screener, in all women subgroups.
Comparison showed differences in items 2 (p = 0 006), 12
(p = 0 000), and 14 (p = 0 042) between nondiabetic women
and diabetic women (Figure 2).
Analysis showed differences between type 1 diabetic
women and nondiabetics in items 11 (p = 0 026), 12 (p =
0 037), and 14 (p = 0 021) (Figure 3) and between type 2
diabetic women and nondiabetics in items 2 (p = 0 002)
and 12 (p = 0 001) (Figure 4).
Figure 5 reflects the percentage of men with positive
criteria for 1 point in each of the 14 items of the dietary
screener, in all men subgroups.
Comparison did not show differences between nondia-
betic men and diabetic men.
Analysis showed differences between type 1 diabetic men
and nondiabetics in the item 9 (p = 0 020) (Figure 6) and
between type 2 diabetic males and nondiabetics in the item
2 (p = 0 046) (Figure 7).
When we compared the 14-item dietary screener score
between age groups in nondiabetic subjects (3 categories:
0–30/31–60 and 61–90 years), the youngest group scored
lower than the oldest group (p = 0 047) (Figure 8).
Analysis showed differences between the youngest
and the oldest in the item 2 (p = 0 004) and in the item 11
(p = 0 007) (Figure 9).
When we compared the 14-item dietary screener score
between age groups in diabetic subjects, no differences
were observed.
4. Discussion
For the whole sample, the 14-item dietary screener score (8.77)
was similar to the score recorded by Ortega-Azorín et al. (8.70)
Table 2: Age in study subgroups.
Age Mean SD p
Women
Type 1 diabetic subjects 44.13 12.00 0.003
Nondiabetic subjects 50.34 10.05
0.000
Type 2 diabetic subjects 66.33 12.20
Men
Type 1 diabetic subjects 49.68 11.72 0.014
Nondiabetic subjects 57.11 11.52
0.021
Type 2 diabetic subjects 63.33 9.97
Table 3: Spearman rank correlations between the 14-item score and









Diabetic patients 15.67 8.54 165 0.008
Type 1 diabetic
patients
19.31 8.3 45 −0.038
Type 2 diabetic
patients
14.3 8.48 119 0.033
Table 1: 14-item Mediterranean diet adherence screener.
Items Criteria for 1 point
(1) Do you use olive oil as main culinary fat? Yes
(2) How much olive oil do you consume in a given day (including oil used for frying, salads,
and out-of-house meals)?
≥4 tablespoons (1 tablespoon = 13.5 g)
(3) How many vegetable servings do you consume per day?
(1 serving: 200 g (consider side dishes as half a serving))
≥2 (≥1 portion raw or as a salad)
(4) How many fruit units (including natural fruit juices) do you consume per day? ≥3
(5) How many servings of red meat, hamburger, or meat products (ham, sausage, etc.)
do you consume per day? (1 serving: 100–150 g)
<1
(6) How many servings of butter, margarine, or cream do you consume per day? (1 serving: 12 g) <1
(7) How many sweet or carbonated beverages do you drink per day? <1
(8) How much wine do you drink per week? ≥7 glasses
(9) How many servings of legumes do you consume per week? (1 serving: 150 g) ≥3
(10) How many servings of fish or shellfish do you consume per week?
(1 serving 100–150 g of fish or 4-5 units or 200 g of shellfish)
≥3
(11) How many times per week do you consume commercial sweets or
pastries (not homemade), such as cakes, cookies, biscuits, or custard?
<3
(12) How many servings of nuts (including peanuts) do you consume per week? (1 serving 30 g) ≥3
(13) Do you preferentially consume chicken, turkey, or rabbit meat instead of veal,
pork, hamburger, or sausage?
Yes
(14) How many times per week do you consume vegetables, pasta, rice, or other dishes seasoned
with sofrito (sauce made with tomato and onion, leek, or garlic and simmered with olive oil)?
≥2
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[10] in Spanish high-cardiovascular risk subjects with type 2
diabetes and nondiabetics, but better than that observed by
Munoz-Pareja et al. (6.83) [31] in the same year in a repre-
sentative sample of noninstitutionalized Spanish population
aged 18 years and over.
Adherence to Mediterranean diet in nondiabetic sub-
jects was 9.06 and in diabetics was 8.54 (type 1 diabetic
patients: 8.30; type 2 diabetic patients: 8.48). Nondiabetics
had much greater adherence to Mediterranean diet than
the sample studied by Salas-Salvado et al. of nondiabetic
individuals at high cardiovascular risk (8.2) [6] and the
nondiabetic subjects studied by Ortega-Azorín et al. (8.7)
[10]. Our type 2 diabetic patients (8.48) exhibited similar
adherence to that found by Ortega-Azorín et al. in type
2 diabetic patients (8.5) [10]. Our type 1 diabetic patients
(8.30) showed less adherence than that found by Carral
et al. (8.9) [32].
Mean indicated moderate adherence to Mediterranean
diet in all subgroups. The majority of patients in all sub-
groups had moderate adherence to Mediterranean diet,
except in the nondiabetic men subgroup, in which, 57.1%
had high adherence.
We did not observe significant correlations in the 14-item
score depending on the duration of diabetes. Similar results
were found by Ortega-Azorín et al. [10].
Diabetics showed less adherence to Mediterranean diet
than the nondiabetic subjects. Diabetic women showed lower
adherence than diabetic men. In fact, women generated lower
Table 4: Comparison of 14-item dietary screener score between nondiabetic subjects and diabetic patients.











Nondiabetics 154 9.06 1.78
Low 2.6
0.006











Diabetic patients 197 8.54 1.81
Low 4.10




Moderate 69.00 High 22.40




Table 5: Comparison of 14-item dietary screener score between type 1 diabetic patients and type 2 diabetic patients.
14-item screener score n Mean SD p Gender n Mean SD p
Type 1 diabetic patients 47 8.30 1.46
0.967
Women 25 7.92 1.60
0.061
Men 22 8.73 1.16
Type 2 diabetic patients 132 8.48 1.92
Women 52 8.12 1.94
0.082





































































































































































































Type 1 diabetic women
Type 2 diabetic women
(%
)
Figure 1: Percentage of women with positive criteria for 1 point in
each of the 14 items of the dietary screener, in all women subgroups.
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Nondiabetic women
Diabetic women
No Yes No Yes No Yes












p = 0.006 p = 0.000
p = 0.042
(14) Use of sofrito sauce ≥ 2/wk
Figure 2: Comparison of items between nondiabetic women and diabetic women.
Nondiabetic women
Type 1 diabetic women
No Yes No Yes No Yes
(11) Commercial sweets and
confectionery ≤ 2/wk












p = 0.026 p = 0.037 p = 0.021


























Figure 4: Comparison of items between nondiabetic women and type 2 diabetic women.
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adherence among diabetics since there were no differences
between diabetic and nondiabetic men in the total score.
Traditional nutritional education for diabetics based on
low-fat diet [4, 33], which promotes weight loss [4, 34],
may be related to the lower adherence shown by type 2 dia-
betic women to Mediterranean diet in items “2: olive oil> 4
tablespoons” and “12: tree nuts≥ 3/week” and by type 2
diabetic men in the item “2: olive oil> 4 tablespoons.” Similar
reasons may be related to the lower adherence shown by type
1 diabetic women to Mediterranean diet on issues “12: tree
nuts≥ 3/week” and “14: use of sofrito sauce≥ 2/week,”
although despite nutritional education for diabetics, they
ate more pastries than nondiabetic women. However, some
good results had been obtained by nutritional education. Bet-
ter punctuations have been obtained by type 1 diabetic men
in the answer to question “9: How many servings of legumes
do you consume per week? (1 serving: 150 g).”
These worst results obtained by type 2 diabetics clearly
showed efforts made to reduce body weight, following a
low-fat diet, but diminishing the adherence to Mediterranean
diet by reducing the intake of olive oil and nuts without
reducing the intake of red meat or butter (similar percentages
between diabetic and nondiabetic individuals).
Our results suggest that future nutritional education pro-
grams should recommend an increase in the consumption of
nuts and olive oil in the diabetic women and of olive oil in the
type 2 diabetic men. Recommendations should take into
account the total fat intake of the diet in order to keep to
the 35% calories from fat, which implies reducing fat intake
from other sources such as red meat, butter, or pastries.
Being overweight, having abdominal fat distribution, and
being obese are the most important risk factors for type 2
diabetes mellitus [35], and increased fat mass contributes to
inflammation [36]. The need to maintain a healthy weight
is a nonsignificant factor.
Itsiopoulos et al. [37] provided a 12-week normocaloric
Mediterranean diet (energy mean 2.600 kcal per day), high
in fat (40% of energy; >50% from monounsaturated fats),
moderate carbohydrate (44% of energy), moderate protein
(12% of energy), moderate alcohol (4% of energy from red
wine) with a large quantity of fruits (563 g/day) and vegeta-
bles (691 g/day), and olive oil (75ml/day) to type 2 diabetic
adults. After 12 weeks, a trend towards weight loss was
observed (body mass index: −0.3). Higher postprandial fat
oxidation rate and higher thermic effect of food following a
meal high in monounsaturated fatty acid [38] and higher die-
tary fibre intake due to large quantities of fruits, vegetables,
and legumes [39] may partly explain the trend towards
weight loss.
To these benefits of a normocaloric Mediterranean diet,
those of a moderately hypocaloric Mediterranean diet may
be added. A hypocaloric Mediterranean diet being equal to
the resting metabolic rate (mean 1.500 kcal per day) has
favoured weight loss (mean 4.9 ± 0.9 kilograms) in obese
women after 2 months [40], and a 12-week hypocaloric Med-
iterranean diet based on the restriction of 40% of habitual
energy intake has led to 6-kilogram weight loss, in patients
with metabolic syndrome [41]. Shai et al. in 2008 prescribed
a moderate-fat, restricted-calorie (1500 kcal per day for
women and 1800 kcal per day for men) Mediterranean diet
to moderately obese subjects. The maximum weight reduc-
tion (−4.4± 6.0 kg) was achieved during the first 6 months;
this period was followed by the 24-month maintenance
phase. Weight loss 24 months postintervention was more
sustainable on Mediterranean diet than on low-fat or low-
carbohydrate diet [4]. Recently, a personalized Mediterra-
nean hypocaloric diet (1400–1600 kcal per day) brought to
an average reduction of body weight of 5.8% at 4 months,
with an improvement in insulin sensitivity [5].
Spain is included in low cardiovascular risk countries in
Europe [42]. Life expectancy in Spain is 10 years older than
the world average, and in both sexes, Spain remains within
the top five positions worldwide [43]. Mediterranean diet
might be one of the factors by which Spain maintains low
levels of cardiovascular risk [2]. The youngest among our
nondiabetic subjects had less adherence to Mediterranean
diet than the oldest ones. They consumed less olive oil and
more pastries. There is a growing evidence that the elderly
people living in Mediterranean area seem to better hold
the traditional healthy dietary habits than the younger ones
[3, 44, 45]. These results point to the decrease in adherence
to Mediterranean diet of the youngest, which may contribute
to increase their lifetime risk of chronic disease.
Today, economic, social, demographic, and health factors
are associated with a more “Westernized” type of diet [46].
Industrialized countries, in the last decades, have lost much





































































































































































































Type 1 diabetic men
Type 2 diabetic men
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Figure 5: Percentage of men with positive criteria for 1 point in
each of the 14 items of the dietary screener, in all men subgroups.
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the arrival in the market of fresh and healthy products. The
2030 Agenda for Sustainable Development, adopted by world
leaders in September 2015, at a United Nations summit, has
identified 17 sustainable development goals, four of which
can be addressed by sustainable food consumption and
sustainable diets. Sustainable diet was defined in 2010 includ-
ing two perspectives: a nutrition perspective, focused on
individuals, and a global sustainability perspective, in all
its dimensions: environmental, economic, and social [47].
Sustainable diets should promote health and well-being of
populations, while being protective of the environment
and preserving of its resources [48]. Local agriculture in
industrialized countries should be supported. Not all coun-
tries grow the same fruits and vegetables, but with the cur-
rent technological advances and respecting the species and
biodiversity of each climate, in all countries, there could be
a greater, better, and cheaper supply of fruits and vegetables.
Countries should be encouraged to provide their popula-
tions with protective foods that satisfy both components of
health and sustainability.
In Spain, the pattern of traditional Mediterranean diet is
being lost. Health professionalsmust encourage the education
and promotion of healthy habits linked to traditional gastron-
omy inMediterranean area. Adoption of a diet by individuals
is a part of the change in the food system, and adoption of
sustainable diets can be facilitated by proper education.
Available scientific evidence on benefits of Mediterranean
diet supports transmission of these healthy habits from health
professionals to the youngest and to patients that could benefit
greatly, such as the diabetic population.
5. Limitations
This research has limitations that should be considered.
Diagnosis of diabetes was self-reported, which means that
Nondiabetic men
Type 1 diabetic men
No Yes




























years, n = 10
Up to 30 years, n = 10
Between 30 and 60
years, n = 82
Between 30 and 60 years, n = 82
More than 60
years, n = 23
More than 60 years, n = 23
Figure 8: Differences between the 14-item score in age groups of
nondiabetic subjects.
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reporting bias cannot be excluded. Our sample may not be
representative of the general Spanish population. It was
composed of adults and elderly from a single urban location,
so it may not be a representative of people from other
geographical areas. However, our findings may be relevant
for the development of recommendations for population-
based approaches to Mediterranean diet.
6. Conclusions
Diabetic women had lower adherence to Mediterranean diet
than nondiabetic women. Diabetic women consumed less
olive oil and less nuts than the nondiabetic ones. Type 2
diabetic men consumed less olive oil than nondiabetic
men. The youngest nondiabetic individuals had less adher-
ence to Mediterranean diet than the older ones. The sample
studied presented moderate adherence to Mediterranean
diet in all subgroups. Scientific evidence about the benefits
of Mediterranean diet, olive oil, and nuts supports the
recommendation to increase consumption of olive oil and
nuts in diabetic women and of daily olive oil in type 2
diabetic men, reducing consumption of red meat, butter,
and pastries, and to promote Mediterranean diet among
the youngest of the sample studied.
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